<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Invasive Malassezia infections</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Invasive Malassezia infections</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Invasive Malassezia infections</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Denis Spelman, MBBS, FRACP, FRCPA, MPH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">CO Morrissey, MB, BCh, FRACP, Grad Dip (Clin Epi), PhD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Carol A Kauffman, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Keri K Hall, MD, MS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 19, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span><em>Malassezia</em> (formerly known as <em>Pityrosporum</em>) species are members of human cutaneous commensal flora, which are associated with a wide spectrum of clinical manifestations from benign skin conditions, such as tinea versicolor and folliculitis, to fungemia in the immunocompromised host [<a href="#rid1">1-4</a>].</p><p>The mycology, epidemiology, clinical manifestations, diagnosis, and treatment of invasive <em>Malassezia </em>infections will be discussed here. The clinical manifestations, diagnosis, and treatment of tinea versicolor and <em>Malassezia</em> folliculitis are discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/4039.html" rel="external">"Tinea versicolor (pityriasis versicolor)"</a> and  <a class="medical medical_review" href="/d/html/103297.html" rel="external">"Infectious folliculitis", section on 'Fungal folliculitis'</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">MYCOLOGY</span><span class="headingEndMark"> — </span><em>Malassezia</em> are lipophilic yeasts that are constituents of the normal human skin flora. Studies have revealed that many <em>Malassezia</em> species produce a biofilm that is used during attachment to host and other surfaces [<a href="#rid5">5</a>]. A recent study showed that invasive <em>Malassezia</em> isolates are more likely to develop biofilms than isolates associated with pityriasis versicolor [<a href="#rid6">6</a>]. These organisms have been classified into at least 17species, including <em>M. furfur</em>, <em>M. pachydermatis</em>, <em>M. sympodialis</em>, <em>M. slooffiae</em>, <em>M. obtusa</em>, <em>M. globosa</em>, and <em>M. restricta</em>, based upon polymerase chain reaction and restriction endonuclease analysis [<a href="#rid2">2,7-11</a>]. A study has reported reliable species identification by matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry following the development of a MALDI-TOF database [<a href="#rid12">12</a>]. In another study evaluating 392 clinical isolates (identified by sequencing) from patients with <em>Malassezia</em> folliculitis and pityriasis versicolor, 68 percent were <em>M. furfur</em> and 19 percent were <em>M. globosa </em>[<a href="#rid13">13</a>].</p><p class="headingAnchor" id="H3"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span><em>Malassezia</em> species mainly colonize the skin and occasionally the respiratory tract [<a href="#rid9">9,14</a>]. The organisms appear to become part of the normal skin microbiota by three to six months of age. <em>M. furfur</em> was recovered from the skin in 32 to 64 percent of neonates in neonatal intensive care units in two separate series [<a href="#rid15">15,16</a>]. In one study, duration of stay in the unit and gestational age were factors favoring skin colonization [<a href="#rid15">15</a>].</p><p>Colonization of the skin with <em>Malassezia</em> and subsequent extension to central venous catheters appears more common in neonates than adults. Studies using scanning electron microscopy have demonstrated that some <em>Malassezia</em> spp produce significant biofilms [<a href="#rid5">5</a>]. <em>M. furfur</em> was recovered from the lumen in 32 percent of percutaneous central venous catheters in a neonatal intensive care unit in one series [<a href="#rid16">16</a>] but not from the insertion sites in 928 adults receiving total <a class="drug drug_general" data-topicid="10307" href="/d/drug information/10307.html" rel="external">parenteral nutrition</a> [<a href="#rid17">17</a>].</p><p>This fact may account for the observation that <em>Malassezia </em>central venous<em> </em>catheter-related infections are more common in preterm neonates than adults. High temperature and humidity may facilitate colonization of catheters, and lipid infusions appear to predispose to both catheter colonization and infections [<a href="#rid18">18-20</a>]. Additional risk factors for <em>Malassezia</em> catheter-related infections in newborns include low birthweight, severe comorbidities, and prolonged arterial catheterization [<a href="#rid21">21</a>]. In a report from a single neonatal intensive care unit, the emergence of <em>M. furfur</em> was associated with the introduction of <a class="drug drug_general" data-topicid="8450" href="/d/drug information/8450.html" rel="external">fluconazole</a> prophylaxis [<a href="#rid22">22</a>].</p><p>Both localized skin and mucosal infections and systemic infections have been reported in hematopoietic cell transplant recipients [<a href="#rid23">23</a>], patients with underlying hematologic malignancies, those receiving monoclonal antibody therapy for cancer [<a href="#rid24">24</a>], and in patients with other immunodeficiency states (eg, solid organ transplantation, diabetes mellitus, prolonged glucocorticoid therapy, HIV) [<a href="#rid25">25</a>]. Unlike many of the other more common opportunistic fungal infections in immunocompromised patients, neutropenia and the use of broad-spectrum antimicrobials do not appear to be significant risk factors for <em>Malassezia</em> infections in hematopoietic cell transplant recipients [<a href="#rid23">23</a>]. In addition, despite the presence of fungemia, disseminated fungal infection is uncommon.</p><p class="headingAnchor" id="H4"><span class="h2">Outbreaks</span><span class="headingEndMark"> — </span>Hospital outbreaks of <em>Malassezia </em>infection have been described [<a href="#rid20">20,21,26</a>]. In one outbreak, there was simultaneous occurrence of <em>M. furfur</em> infection in three patients in neighboring beds in an intensive care unit [<a href="#rid26">26</a>]. In a second outbreak, the organism was isolated from the hands of health care workers and the health care workers' pet dogs; all isolates had an identical pattern of restriction fragment length polymorphisms [<a href="#rid21">21</a>]. An outbreak in a neonatal intensive care unit, which was caused by multiple <em>Malassezia</em> genotypes, has also been described [<a href="#rid27">27</a>]. Although a source was not identified, effective infection prevention methods included removal of a lipid-rich moisturizing hand cream used by staff.</p><p class="headingAnchor" id="H5"><span class="h1">CLINICAL PRESENTATION</span><span class="headingEndMark"> — </span><em>Malassezia</em> infections can be localized and/or systemic in immunocompromised hosts. <em>Malassezia </em>spp<em> </em>can produce the following clinical syndromes:</p><p class="bulletIndent1"><span class="glyph">●</span><em>Malassezia</em> folliculitis presents with pruritic, monomorphic, follicular papules or pustules on the chest, back, and/or shoulders. Less frequent sites of involvement include the face, neck, and extensor side of the arms. (See  <a class="medical medical_review" href="/d/html/103297.html" rel="external">"Infectious folliculitis", section on 'Fungal folliculitis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Catheter-related fungemia, especially in preterm neonates receiving lipid infusions (ie, total <a class="drug drug_general" data-topicid="10307" href="/d/drug information/10307.html" rel="external">parenteral nutrition</a>) through a central venous catheter [<a href="#rid20">20</a>] – The clinical examination, apart from fever, may be unremarkable [<a href="#rid23">23</a>]. Both septic thrombosis of the superior vena cava [<a href="#rid28">28</a>] and peripheral thromboembolism [<a href="#rid29">29</a>] have been described.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Localized infections, including meningitis and urinary tract infections have been described [<a href="#rid21">21</a>]. Rarely, <em>Malassezia</em> species have been implicated in cases of peritonitis, mastitis, septic arthritis, sinusitis, and hepatic abscess [<a href="#rid25">25,30,31</a>].</p><p></p><p class="headingAnchor" id="H6"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>In patients with fungemia, meningitis, peritonitis, or septic arthritis, a definitive diagnosis is made by detection of characteristic yeasts on microscopy in the microbiology laboratory, on histologic or cytologic examination of a biopsy, or needle aspirate specimen or positive culture from a sterile site (<a class="graphic graphic_picture graphicRef71053" href="/d/graphic/71053.html" rel="external">picture 1</a>) [<a href="#rid32">32</a>]. The optimal blood culture system for <em>Malassezia</em> has not been determined, but there are reports of positive blood cultures using both the pediatric isolator and the BacT/Alert systems [<a href="#rid33">33</a>]. Prolonged incubation of up to two weeks has been recommended for isolation [<a href="#rid34">34</a>]. The culture of <em>Malassezia</em> spp from urine in the absence of a urinary catheter or from a sinus aspirate is diagnostic of <em>Malassezia</em> urinary tract infection or sinusitis, respectively.</p><p><em>Malassezia</em> require fatty acids for growth and, thus, do not grow on routine laboratory media. If the diagnosis of <em>Malassezia</em> infection is suspected based on the morphologic findings, the specimen should be plated onto specialized media, such as Dixon agar, which contains glycerol mono-oleate, or Sabouraud dextrose agar, covered with a layer of olive oil and incubated at 37ºC [<a href="#rid21">21,23,25,26,28,29,35,36</a>]. </p><p>On microscopy, <em>Malassezia</em> have characteristic features. The yeast is typically thick walled (3 to 8 microns in diameter), round to oval in shape, with a broad-based bud and collarette at one pole. Hyphae and pseudohyphae are rarely seen [<a href="#rid23">23</a>]. This microscopic finding has been described as the "spaghetti and meatballs" appearance [<a href="#rid37">37</a>]. Identification is usually confirmed on the basis of microscopic appearance and the need for specialized media.</p><p>Newer methods of identification of <em>Malassezia</em> spp include matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF) [<a href="#rid38">38,39</a>] and multiplex polymerase chain reaction (PCR) [<a href="#rid40">40</a>]. These methods may be useful adjunctive tests for rapid identification, particularly in outbreak settings. With MALDI-TOF, the spectra of most species have not as yet been included in current databases, but this methodology has been successful when the database has been expanded to include numerous <em>Malassezia</em> species [<a href="#rid39">39</a>].</p><p>Serum (1,3)-beta-D-glucan was assessed for the diagnosis of invasive yeast infection in 47 neonates in a neonatal intensive care unit but does not appear to be positive in the setting of invasive <em>Malassezia</em> infection [<a href="#rid41">41</a>].</p><p>The diagnosis of <em>Malassezia</em> folliculitis is discussed separately. (See  <a class="medical medical_review" href="/d/html/103297.html" rel="external">"Infectious folliculitis", section on 'Malassezia (Pityrosporum) folliculitis'</a>.)</p><p class="headingAnchor" id="H7"><span class="h1">SUSCEPTIBILITY TESTING</span><span class="headingEndMark"> — </span>Because <em>Malassezia</em> spp do not grow on the recommended susceptibility media, susceptibility testing has not been standardized for this organism. Reported minimum inhibitory concentrations (MIC) values for <a class="drug drug_general" data-topicid="9677" href="/d/drug information/9677.html" rel="external">terbinafine</a>, amphotericin B, and the azoles vary among species [<a href="#rid11">11,13,42</a>]. Reports have described experience with optimized broth microdilution and E-tests methodologies [<a href="#rid43">43-45</a>]. In vitro, all <em>Malassezia</em> spp appear susceptible to amphotericin B (0.3 to 2.5 mcg/mL) and azole agents, including <a class="drug drug_general" data-topicid="8589" href="/d/drug information/8589.html" rel="external">ketoconazole</a>, <a class="drug drug_general" data-topicid="8586" href="/d/drug information/8586.html" rel="external">itraconazole</a>, <a class="drug drug_general" data-topicid="10118" href="/d/drug information/10118.html" rel="external">voriconazole</a> (0.016 to 0.25 mcg/mL), and <a class="drug drug_general" data-topicid="9479" href="/d/drug information/9479.html" rel="external">posaconazole</a>. However, the MIC for <a class="drug drug_general" data-topicid="8450" href="/d/drug information/8450.html" rel="external">fluconazole</a> are somewhat higher (0.5 to 6.5 mcg/mL) [<a href="#rid46">46,47</a>]. One study, performed in India, reported that itraconazole had the lowest MIC values (0.125 to 1 mcg/ml) [<a href="#rid48">48</a>]. <em>Malassezia </em>spp have variable susceptibility to terbinafine with MICs that range from 0.06 mcg/mL for <em>M. globosa</em> to 32 mcg/mL for <em>M. furfur </em>[<a href="#rid46">46,47</a>]. Synergism has been reported between terbinafine and itraconazole and between <a class="drug drug_general" data-topicid="9971" href="/d/drug information/9971.html" rel="external">tacrolimus</a> and itraconazole, ketoconazole, and terbinafine, although the clinical significance of such synergism is unclear [<a href="#rid13">13</a>]. Echinocandins and <a class="drug drug_general" data-topicid="8502" href="/d/drug information/8502.html" rel="external">griseofulvin</a> appear to have no activity against <em>Malassezia</em> spp [<a href="#rid43">43,49</a>].</p><p class="headingAnchor" id="H8"><span class="h1">TREATMENT</span><span class="headingEndMark"> — </span>Central venous catheter-related <em>Malassezia </em>infections are usually treated with catheter removal, discontinuation of the lipid infusion (ie, total <a class="drug drug_general" data-topicid="10307" href="/d/drug information/10307.html" rel="external">parenteral nutrition</a>), and administration of antifungal therapy [<a href="#rid23">23</a>]. However, there are reports of successful eradication of infection with antifungal therapy without catheter removal [<a href="#rid25">25</a>] and with catheter removal without systemic antifungal treatment [<a href="#rid23">23</a>].</p><p>For treatment of most patients with <em>Malassezia</em> infection, we use a lipid formulation of amphotericin B (3 to 5 mg/kg intravenously [IV] daily); <em>Malassezia</em> are lipophilic yeasts and it has been suggested that lipid formulations of amphotericin may have more activity against <em>Malassezia</em> than nonlipid formulations<em> </em>but this is unproven [<a href="#rid34">34</a>]. An exception is the rare occurrence of urinary tract infection for which we use <a class="drug drug_general" data-topicid="8701" href="/d/drug information/8701.html" rel="external">amphotericin B deoxycholate</a> (0.3 to 0.5 mg/kg IV once daily) in adults because lipid formulations of amphotericin B do not achieve adequate concentrations in the urine. (See  <a class="medical medical_review" href="/d/html/2415.html" rel="external">"Candida infections of the bladder and kidneys", section on 'Fluconazole-resistant Candida'</a>.)</p><p>In neonates with <em>Malassezia</em> infection, <a class="drug drug_general" data-topicid="8701" href="/d/drug information/8701.html" rel="external">amphotericin B deoxycholate</a> (0.7 mg/kg IV once daily) is used rather than a lipid formulation.</p><p>Therapy with <a class="drug drug_general" data-topicid="10118" href="/d/drug information/10118.html" rel="external">voriconazole</a>, <a class="drug drug_general" data-topicid="9479" href="/d/drug information/9479.html" rel="external">posaconazole</a>, or <a class="drug drug_general" data-topicid="8586" href="/d/drug information/8586.html" rel="external">itraconazole</a> is an alternative option, based on in vitro data rather than clinical studies. <a class="drug drug_general" data-topicid="8450" href="/d/drug information/8450.html" rel="external">Fluconazole</a> should not be used because its in vitro activity is inferior to the in vitro activity of the other azoles. Patients who develop <em>Malassezia</em> bloodstream infections while receiving fluconazole prophylaxis should be treated with a different antifungal agent [<a href="#rid34">34</a>]. </p><p>There are no reports of treatment of <em>Malassezia</em> with echinocandins, most likely related to the lack of in vitro activity of this class of antifungal agents against <em>Malassezia</em> species. (See <a class="local">'Susceptibility testing'</a> above.)</p><p>The management of folliculitis caused by <em>Malassezia</em> spp is discussed separately. (See  <a class="medical medical_review" href="/d/html/103297.html" rel="external">"Infectious folliculitis", section on 'Malassezia folliculitis'</a>.)</p><p class="headingAnchor" id="H9"><span class="h1">OUTCOME OF INFECTION</span><span class="headingEndMark"> — </span>With catheter removal and discontinuation of intravenous lipids (ie, total <a class="drug drug_general" data-topicid="10307" href="/d/drug information/10307.html" rel="external">parenteral nutrition</a>), the outcome is usually favorable, even in transplant patients with fungemia [<a href="#rid23">23</a>].</p><p>In 11 cases of folliculitis occurring in heart transplant recipients, six responded to topical applications of <a class="drug drug_general" data-topicid="9287" href="/d/drug information/9287.html" rel="external">clotrimazole</a> (1%) and <a class="drug drug_general" data-topicid="9885" href="/d/drug information/9885.html" rel="external">selenium sulfide</a>, and the remainder responded to <a class="drug drug_general" data-topicid="8450" href="/d/drug information/8450.html" rel="external">fluconazole</a> [<a href="#rid35">35</a>].</p><p class="headingAnchor" id="H10"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical significance</strong> – <em>Malassezia</em> species are members of human cutaneous commensal microbiota and are associated with intravascular catheter-related infections and folliculitis in the immunocompromised host. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk factors</strong> – Central venous catheter-related bloodstream infections are seen most commonly in premature neonates receiving lipid infusions (ie, total <a class="drug drug_general" data-topicid="10307" href="/d/drug information/10307.html" rel="external">parenteral nutrition</a> [TPN]). Additional risk factors include low birthweight, severe comorbidities, and arterial catheterization for longer than nine days. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – A definitive diagnosis is made by culture from a sterile site. If the diagnosis of <em>Malassezia</em> infection is being considered, Sabouraud dextrose agar must be plated at 37ºC, and the specimen must be covered with a layer of olive oil. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment</strong> – For patients other than neonates, we recommend the administration of a lipid formulation of amphotericin B for treatment of central venous catheter-related <em>Malassezia </em>infections (<a class="grade" href="https://medilib.ir/uptodate/show/grade_2" rel="external">Grade 1B</a>). For neonates, <a class="drug drug_general" data-topicid="8701" href="/d/drug information/8701.html" rel="external">amphotericin B deoxycholate</a> is preferred over the lipid formulations. Therapy with <a class="drug drug_general" data-topicid="10118" href="/d/drug information/10118.html" rel="external">voriconazole</a>, <a class="drug drug_general" data-topicid="9479" href="/d/drug information/9479.html" rel="external">posaconazole</a>, or <a class="drug drug_general" data-topicid="8586" href="/d/drug information/8586.html" rel="external">itraconazole</a> is an alternative option. </p><p></p><p class="bulletIndent1">We also suggest central venous catheter removal and discontinuation of lipid infusions (ie, TPN) (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). (See <a class="local">'Treatment'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Crespo-Erchiga V, Florencio VD. Malassezia yeasts and pityriasis versicolor. Curr Opin Infect Dis 2006; 19:139.</a></li><li><a class="nounderline abstract_t">Ben Salah S, Makni F, Marrakchi S, et al. Identification of Malassezia species from Tunisian patients with pityriasis versicolor and normal subjects. Mycoses 2005; 48:242.</a></li><li><a class="nounderline abstract_t">Jahagirdar BN, Morrison VA. Emerging fungal pathogens in patients with hematologic malignancies and marrow/stem-cell transplant recipients. Semin Respir Infect 2002; 17:113.</a></li><li><a class="nounderline abstract_t">Ashbee HR, Evans EG. Immunology of diseases associated with Malassezia species. Clin Microbiol Rev 2002; 15:21.</a></li><li><a class="nounderline abstract_t">Angiolella L, Leone C, Rojas F, et al. Biofilm, adherence, and hydrophobicity as virulence factors in Malassezia furfur. Med Mycol 2018; 56:110.</a></li><li><a class="nounderline abstract_t">Rhimi W, Chebil W, Ugochukwu ICI, et al. Comparison of virulence factors and susceptibility profiles of Malassezia furfur from pityriasis versicolor patients and bloodstream infections of preterm infants. Med Mycol 2022; 61.</a></li><li><a class="nounderline abstract_t">Gupta AK, Kohli Y, Faergemann J, Summerbell RC. Epidemiology of Malassezia yeasts associated with pityriasis versicolor in Ontario, Canada. Med Mycol 2001; 39:199.</a></li><li><a class="nounderline abstract_t">Gupta AK, Kohli Y, Summerbell RC. Molecular differentiation of seven Malassezia species. J Clin Microbiol 2000; 38:1869.</a></li><li><a class="nounderline abstract_t">Gaitanis G, Magiatis P, Hantschke M, et al. The Malassezia genus in skin and systemic diseases. Clin Microbiol Rev 2012; 25:106.</a></li><li><a class="nounderline abstract_t">Ilahi A, Hadrich I, Neji S, et al. Real-Time PCR Identification of Six Malassezia Species. Curr Microbiol 2017; 74:671.</a></li><li><a class="nounderline abstract_t">Theelen B, Cafarchia C, Gaitanis G, et al. Malassezia ecology, pathophysiology, and treatment. Med Mycol 2018; 56:S10.</a></li><li><a class="nounderline abstract_t">Denis J, Machouart M, Morio F, et al. Performance of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identifying Clinical Malassezia Isolates. J Clin Microbiol 2017; 55:90.</a></li><li><a class="nounderline abstract_t">Li W, Zhang ZW, Luo Y, et al. Molecular epidemiology, in vitro susceptibility and exoenzyme screening of Malassezia clinical isolates. J Med Microbiol 2020; 69:436.</a></li><li><a class="nounderline abstract_t">Smolinski KN, Shah SS, Honig PJ, Yan AC. Neonatal cutaneous fungal infections. Curr Opin Pediatr 2005; 17:486.</a></li><li><a class="nounderline abstract_t">Ashbee HR, Leck AK, Puntis JW, et al. Skin colonization by Malassezia in neonates and infants. Infect Control Hosp Epidemiol 2002; 23:212.</a></li><li><a class="nounderline abstract_t">Aschner JL, Punsalang A Jr, Maniscalco WM, Menegus MA. Percutaneous central venous catheter colonization with Malassezia furfur: incidence and clinical significance. Pediatrics 1987; 80:535.</a></li><li><a class="nounderline abstract_t">Jatoi A, Hanjosten K, Ross E, Mason JB. A prospective survey for central line skin-site colonization by the pathogen Malassezia furfur among hospitalized adults receiving total parenteral nutrition. JPEN J Parenter Enteral Nutr 1997; 21:230.</a></li><li><a class="nounderline abstract_t">Gupta AK, Kohli Y, Li A, et al. In vitro susceptibility of the seven Malassezia species to ketoconazole, voriconazole, itraconazole and terbinafine. Br J Dermatol 2000; 142:758.</a></li><li><a class="nounderline abstract_t">Papavassilis C, Mach KK, Mayser PA. Medium-chain triglycerides inhibit growth of Malassezia: implications for prevention of systemic infection. Crit Care Med 1999; 27:1781.</a></li><li><a class="nounderline abstract_t">Chryssanthou E, Broberger U, Petrini B. Malassezia pachydermatis fungaemia in a neonatal intensive care unit. Acta Paediatr 2001; 90:323.</a></li><li><a class="nounderline abstract_t">Chang HJ, Miller HL, Watkins N, et al. An epidemic of Malassezia pachydermatis in an intensive care nursery associated with colonization of health care workers' pet dogs. N Engl J Med 1998; 338:706.</a></li><li><a class="nounderline abstract_t">Chen IT, Chen CC, Huang HC, Kuo KC. Malassezia furfur Emergence and Candidemia Trends in a Neonatal Intensive Care Unit During 10 Years: The Experience of Fluconazole Prophylaxis in a Single Hospital. Adv Neonatal Care 2020; 20:E3.</a></li><li><a class="nounderline abstract_t">Morrison VA, Weisdorf DJ. The spectrum of Malassezia infections in the bone marrow transplant population. Bone Marrow Transplant 2000; 26:645.</a></li><li><a class="nounderline abstract_t">Cholongitas E, Pipili C, Ioannidou D. Malassezia folliculitis presented as acneiform eruption after cetuximab administration. J Drugs Dermatol 2009; 8:274.</a></li><li><a class="nounderline abstract_t">Barber GR, Brown AE, Kiehn TE, et al. Catheter-related Malassezia furfur fungemia in immunocompromised patients. Am J Med 1993; 95:365.</a></li><li><a class="nounderline abstract_t">Archer-Dubon C, Icaza-Chivez ME, Orozco-Topete R, et al. An epidemic outbreak of Malassezia folliculitis in three adult patients in an intensive care unit: a previously unrecognized nosocomial infection. Int J Dermatol 1999; 38:453.</a></li><li><a class="nounderline abstract_t">Ilahi A, Hadrich I, Goudjil S, et al. Molecular epidemiology of a Malassezia pachydermatis neonatal unit outbreak. Med Mycol 2018; 56:69.</a></li><li><a class="nounderline abstract_t">Schleman KA, Tullis G, Blum R. Intracardiac mass complicating Malassezia furfur fungemia. Chest 2000; 118:1828.</a></li><li><a class="nounderline abstract_t">Kessler AT, Kourtis AP, Simon N. Peripheral thromboembolism associated with Malassezia furfur sepsis. Pediatr Infect Dis J 2002; 21:356.</a></li><li><a class="nounderline abstract_t">Gidding H, Hawes L, Dwyer B. The isolation of Malassezia furfur from an episode of peritonitis. Med J Aust 1989; 151:603.</a></li><li><a class="nounderline abstract_t">Cantey JB, Dallas SD, Cigarroa FG, Quinn AF. Malassezia Hepatic Abscess in a Neonate. Pediatr Infect Dis J 2020; 39:1043.</a></li><li><a class="nounderline abstract_t">Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34:7.</a></li><li><a class="nounderline abstract_t">Iatta R, Battista M, Miragliotta G, et al. Blood culture procedures and diagnosis of Malassezia furfur bloodstream infections: Strength and weakness. Med Mycol 2018; 56:828.</a></li><li><a class="nounderline abstract_t">Pedrosa AF, Lisboa C, Rodrigues AG. Malassezia infections with systemic involvement: Figures and facts. J Dermatol 2018; 45:1278.</a></li><li><a class="nounderline abstract_t">Rhie S, Turcios R, Buckley H, Suh B. Clinical features and treatment of Malassezia folliculitis with fluconazole in orthotopic heart transplant recipients. J Heart Lung Transplant 2000; 19:215.</a></li><li><a class="nounderline abstract_t">Shparago NI, Bruno PP, Bennett J. Systemic Malassezia furfur infection in an adult receiving total parenteral nutrition. J Am Osteopath Assoc 1995; 95:375.</a></li><li><a class="nounderline abstract_t">Andrade-Filho Jde S. Analogies in medicine: spaghetti and meatballs. Rev Inst Med Trop Sao Paulo 2013; 55.</a></li><li><a class="nounderline abstract_t">Kolecka A, Khayhan K, Arabatzis M, et al. Efficient identification of Malassezia yeasts by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). Br J Dermatol 2014; 170:332.</a></li><li><a class="nounderline abstract_t">Honnavar P, Ghosh AK, Paul S, et al. Identification of Malassezia species by MALDI-TOF MS after expansion of database. Diagn Microbiol Infect Dis 2018; 92:118.</a></li><li><a class="nounderline abstract_t">Vuran E, Karaarslan A, Karasartova D, et al. Identification of Malassezia species from pityriasis versicolor lesions with a new multiplex PCR method. Mycopathologia 2014; 177:41.</a></li><li><a class="nounderline abstract_t">Cornu M, Goudjil S, Kongolo G, et al. Evaluation of the (1,3)-β-D-glucan assay for the diagnosis of neonatal invasive yeast infections. Med Mycol 2018; 56:78.</a></li><li><a class="nounderline abstract_t">Arendrup MC, Boekhout T, Akova M, et al. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections. Clin Microbiol Infect 2014; 20 Suppl 3:76.</a></li><li><a class="nounderline abstract_t">Leong C, Buttafuoco A, Glatz M, Bosshard PP. Antifungal Susceptibility Testing of Malassezia spp. with an Optimized Colorimetric Broth Microdilution Method. J Clin Microbiol 2017; 55:1883.</a></li><li><a class="nounderline abstract_t">Galvis-Marín JC, Rodríguez-Bocanegra MX, Pulido-Villamarín ADP, et al. [In vitro antifungal activity of azoles and amphotericin B against Malassezia furfur by the CLSI M27-A3 microdilution and Etest® methods]. Rev Iberoam Micol 2017; 34:89.</a></li><li><a class="nounderline abstract_t">Rojas FD, Córdoba SB, de Los Ángeles Sosa M, et al. Antifungal susceptibility testing of Malassezia yeast: comparison of two different methodologies. Mycoses 2017; 60:104.</a></li><li><a class="nounderline abstract_t">Marcon MJ, Durrell DE, Powell DA, Buesching WJ. In vitro activity of systemic antifungal agents against Malassezia furfur. Antimicrob Agents Chemother 1987; 31:951.</a></li><li><a class="nounderline abstract_t">Sugita T, Tajima M, Ito T, et al. Antifungal activities of tacrolimus and azole agents against the eleven currently accepted Malassezia species. J Clin Microbiol 2005; 43:2824.</a></li><li><a class="nounderline abstract_t">Romald PN, Kindo AJ, Mahalakshmi V, Umadevi U. Epidemiological pattern of Malassezia, its phenotypic identification and antifungal susceptibility profile to azoles by broth microdilution method. Indian J Med Microbiol 2020; 38:351.</a></li><li><a class="nounderline abstract_t">Tragiannidis A, Bisping G, Koehler G, Groll AH. Minireview: Malassezia infections in immunocompromised patients. Mycoses 2010; 53:187.</a></li></ol></div><div id="topicVersionRevision">Topic 2428 Version 23.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16514338" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Malassezia yeasts and pityriasis versicolor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15982205" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Identification of Malassezia species from Tunisian patients with pityriasis versicolor and normal subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12070830" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Emerging fungal pathogens in patients with hematologic malignancies and marrow/stem-cell transplant recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11781265" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Immunology of diseases associated with Malassezia species.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28340187" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Biofilm, adherence, and hydrophobicity as virulence factors in Malassezia furfur.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36626926" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Comparison of virulence factors and susceptibility profiles of Malassezia furfur from pityriasis versicolor patients and bloodstream infections of preterm infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11346269" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Epidemiology of Malassezia yeasts associated with pityriasis versicolor in Ontario, Canada.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10790115" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Molecular differentiation of seven Malassezia species.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22232373" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : The Malassezia genus in skin and systemic diseases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28332161" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Real-Time PCR Identification of Six Malassezia Species.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29538738" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Malassezia ecology, pathophysiology, and treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27795342" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Performance of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identifying Clinical Malassezia Isolates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32068525" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Molecular epidemiology, in vitro susceptibility and exoenzyme screening of Malassezia clinical isolates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16012261" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Neonatal cutaneous fungal infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12002236" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Skin colonization by Malassezia in neonates and infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3658573" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Percutaneous central venous catheter colonization with Malassezia furfur: incidence and clinical significance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9252950" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : A prospective survey for central line skin-site colonization by the pathogen Malassezia furfur among hospitalized adults receiving total parenteral nutrition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10792228" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : In vitro susceptibility of the seven Malassezia species to ketoconazole, voriconazole, itraconazole and terbinafine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10507598" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Medium-chain triglycerides inhibit growth of Malassezia: implications for prevention of systemic infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11332175" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Malassezia pachydermatis fungaemia in a neonatal intensive care unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9494146" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : An epidemic of Malassezia pachydermatis in an intensive care nursery associated with colonization of health care workers' pet dogs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31306235" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Malassezia furfur Emergence and Candidemia Trends in a Neonatal Intensive Care Unit During 10 Years: The Experience of Fluconazole Prophylaxis in a Single Hospital.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11035371" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : The spectrum of Malassezia infections in the bone marrow transplant population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19271376" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Malassezia folliculitis presented as acneiform eruption after cetuximab administration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8213867" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Catheter-related Malassezia furfur fungemia in immunocompromised patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10397586" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : An epidemic outbreak of Malassezia folliculitis in three adult patients in an intensive care unit: a previously unrecognized nosocomial infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28371911" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Molecular epidemiology of a Malassezia pachydermatis neonatal unit outbreak.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11115482" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Intracardiac mass complicating Malassezia furfur fungemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12075774" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Peripheral thromboembolism associated with Malassezia furfur sepsis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2593898" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : The isolation of Malassezia furfur from an episode of peritonitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32496411" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Malassezia Hepatic Abscess in a Neonate.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11731939" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29294025" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Blood culture procedures and diagnosis of Malassezia furfur bloodstream infections: Strength and weakness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30264900" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Malassezia infections with systemic involvement: Figures and facts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10703699" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Clinical features and treatment of Malassezia folliculitis with fluconazole in orthotopic heart transplant recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7615409" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Systemic Malassezia furfur infection in an adult receiving total parenteral nutrition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23740010" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Analogies in medicine: spaghetti and meatballs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24125026" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Efficient identification of Malassezia yeasts by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30025965" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Identification of Malassezia species by MALDI-TOF MS after expansion of database.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24190515" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Identification of Malassezia species from pityriasis versicolor lesions with a new multiplex PCR method.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28371838" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Evaluation of the (1,3)-β-D-glucan assay for the diagnosis of neonatal invasive yeast infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24102785" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28381607" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Antifungal Susceptibility Testing of Malassezia spp. with an Optimized Colorimetric Broth Microdilution Method.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28214276" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : [In vitro antifungal activity of azoles and amphotericin B against Malassezia furfur by the CLSI M27-A3 microdilution and Etest®methods].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27625339" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Antifungal susceptibility testing of Malassezia yeast: comparison of two different methodologies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3619430" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : In vitro activity of systemic antifungal agents against Malassezia furfur.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15956404" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Antifungal activities of tacrolimus and azole agents against the eleven currently accepted Malassezia species.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33154246" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Epidemiological pattern of Malassezia, its phenotypic identification and antifungal susceptibility profile to azoles by broth microdilution method.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20028460" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Minireview: Malassezia infections in immunocompromised patients.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
